News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Omega Fund IV, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
SC 13G/A
| Omega Fund IV, L.P. reports a 10.6% stake in Replimune Group, Inc. |
| 11/23/2021 |
4
| Omega Fund IV, L.P. (10% Owner) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 34,845 shares
@ $34.54, valued at
$1.2M
Sold 417 shares
@ $34.8, valued at
$14.5k
Sold 10,162 shares
@ $34.7, valued at
$352.6k
|
|
| 11/18/2021 |
4
| Omega Fund IV, L.P. (10% Owner) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 153 shares
@ $33.5, valued at
$5.1k
Sold 2,441 shares
@ $33.5, valued at
$81.8k
|
|
| 11/18/2021 |
4
| Omega Fund IV, L.P. (10% Owner) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 153 shares
@ $33.5, valued at
$5.1k
Sold 2,441 shares
@ $33.5, valued at
$81.8k
|
|
| 11/16/2021 |
4
| Omega Fund IV, L.P. (10% Owner) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 23,235 shares
@ $33.66, valued at
$782.1k
Sold 782 shares
@ $33.66, valued at
$26.3k
|
|
| 11/12/2021 |
4
| Omega Fund IV, L.P. (10% Owner) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 11 shares
@ $33.5, valued at
$368.5
Sold 18,279 shares
@ $33.61, valued at
$614.4k
|
|
| 11/10/2021 |
4
| Omega Fund IV, L.P. (10% Owner) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 3,817 shares
@ $33.53, valued at
$128k
Sold 7,537 shares
@ $33.73, valued at
$254.2k
|
|
| 11/08/2021 |
4
| Omega Fund IV, L.P. (10% Owner) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 25,225 shares
@ $33.58, valued at
$847.1k
Sold 5,790 shares
@ $33.5, valued at
$194k
|
|
| 09/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| Omega Fund IV, L.P. (10% Owner) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 26,957 shares
@ $45.34, valued at
$1.2M
Sold 3,393 shares
@ $46.04, valued at
$156.2k
|
|
| 01/26/2021 |
4
| Omega Fund IV, L.P. (10% Owner) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Sold 8,090 shares
@ $45.05, valued at
$364.5k
Sold 3,269 shares
@ $45.03, valued at
$147.2k
|
|
| 01/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/06/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 04/03/2020 |
4
| Omega Fund IV, L.P. (10% Owner) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 16,500 options to buy
@ $9.78, valued at
$161.4k
|
|
| 02/14/2020 |
SC 13G/A
| Omega Fund IV, L.P. reports a 16.5% stake in Replimune Group, Inc. |
| 02/14/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2020 |
SC 13G/A
| Omega Fund IV, L.P. reports a 4% stake in Translate Bio, Inc. |
| 11/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/03/2019 |
4
| Omega Fund IV, L.P. (10% Owner) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Granted 13,500 options to buy
@ $15.5, valued at
$209.3k
|
|
| 02/13/2019 |
SC 13G
| Omega Fund IV, L.P. reports a 5.4% stake in § 240.13d-2 Translate Bio, Inc. |
| 02/13/2019 |
SC 13G
| Omega Fund IV, L.P. reports a 16.2% stake in § 240.13d-2 Replimune Group, Inc. |
| 02/13/2019 |
SC 13D
| Omega Fund IV, L.P. reports a 17.2% stake in ESSA Pharma Inc. |
| 07/25/2018 |
4
| Omega Fund IV, L.P. (10% Owner) has filed a Form 4 on Replimune Group, Inc.|
Txns:
| Bought 266,667 shares
@ $15, valued at
$4M
Converted 994,688 shares
@ $0
Converted 2,579,881 shares
@ $0
Converted 1,013,547 shares
@ $0
Converted 25,000 options to buy
@ $0
Converted 248,672 warrants
@ $0
Converted 100,000 options to buy
@ $0
Converted 259,366 convertible preferred
@ $0
Converted 101,896 convertible preferred
@ $0
Granted 13,500 options
@ $15, valued at
$202.5k
|
|
| 07/19/2018 |
3
| Omega Fund IV, L.P. (10% Owner) has filed a Form 3 on Replimune Group, Inc. |
| 07/03/2018 |
4
| Omega Fund IV, L.P. (10% Owner) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Converted 979,179 shares
@ $0
Converted 979,179 shares
@ $0
Converted 1,458,424 shares
@ $0
Converted 1,458,424 shares
@ $0
Converted 2,500,000 preferred shares
@ $0
Converted 2,500,000 preferred shares
@ $0
Converted 1,676,348 preferred shares
@ $0
Converted 1,676,348 preferred shares
@ $0
Converted 1,263,484 preferred shares
@ $0
Converted 1,263,484 preferred shares
@ $0
Converted 5,800,000 preferred shares
@ $0 |
|
| 06/27/2018 |
3
| Omega Fund IV, L.P. (10% Owner) has filed a Form 3 on Translate Bio, Inc. |
| 06/25/2018 |
4
| Omega Fund IV, L.P. (Former 10% Owner) has filed a Form 4 on Kezar Life Sciences, Inc.|
Txns:
| Converted 315,489 shares
@ $0
Converted 315,489 shares
@ $0
Converted 377,783 shares
@ $0
Converted 377,783 shares
@ $0
Converted 315,489 options to buy
@ $0
Converted 315,489 options to buy
@ $0
Converted 377,783 options to buy
@ $0
Converted 377,783 options to buy
@ $0 |
|
| 06/20/2018 |
3
| Omega Fund IV, L.P. (10% Owner) has filed a Form 3 on Kezar Life Sciences, Inc. |
|
|
|